These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 18326535

  • 1. Occurrence of cold agglutinin disease in RA patient during etanercept therapy successfully treated with rituximab.
    Malesci D, La Montagna G.
    Rheumatology (Oxford); 2008 May; 47(5):734-5. PubMed ID: 18326535
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of rheumatoid arthritis with etanercept.
    Genovese MC, Kremer JM.
    Rheum Dis Clin North Am; 2004 May; 30(2):311-28, vi-vii. PubMed ID: 15172043
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers.
    Seong SS, Choi CB, Woo JH, Bae KW, Joung CL, Uhm WS, Kim TH, Jun JB, Yoo DH, Lee JT, Bae SC.
    J Rheumatol; 2007 Apr; 34(4):706-11. PubMed ID: 17309133
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists.
    Fernández-Nebro A, Tomero E, Ortiz-Santamaría V, Castro MC, Olivé A, de Haro M, Portales RG, González-Mari MV, Laffón A, García-Vicuña R.
    Am J Med; 2005 May; 118(5):552-6. PubMed ID: 15866260
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Etanercept for therapy of rheumatoid arthritis].
    Miyasaka N.
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():521-5. PubMed ID: 15799411
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ocular inflammatory disease in patients with RA taking etanercept: is discontinuation of etanercept necessary?
    Tiliakos AN, Tiliakos NA.
    J Rheumatol; 2003 Dec; 30(12):2727. PubMed ID: 14719226
    [No Abstract] [Full Text] [Related]

  • 18. Do tumor-necrosis-factor inhibitors prevent first cardiovascular events in patients with rheumatoid arthritis?
    Kaplan MJ.
    Nat Clin Pract Rheumatol; 2005 Dec; 1(2):74-5. PubMed ID: 16932633
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Etanercept-associated SLE with lupus nephritis.
    Neradová A, Stam F, van den Berg JG, Bax WA.
    Lupus; 2009 Jun; 18(7):667-8. PubMed ID: 19433471
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.